It was the first time since 2012 that AbbVie’s rheumatoid arthritis biologic Humira didn’t top the list of hospitals’ highest drug expenditures.
Join The Ecosystem
It was the first time since 2012 that AbbVie’s rheumatoid arthritis biologic Humira didn’t top the list of hospitals’ highest drug expenditures.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.